Abstract |
HSV infections are treated efficiently and prevented by acyclovir, although resistant strains have been reported. Resistance to acyclovir involves mainly mutations in the viral gene encoding thymidine kinase; mutations may lead to an altered or, more frequently, deficient TK. These acyclovir-resistant TK deficient strains are not able to reactivate from a latent infection in an experimental model, compared to TK positive strains. A case is reported of a bone marrow transplant child who developed HSV infection at 11 days post- transplantation. Acyclovir-resistant HSV 1 was isolated on day 19 post- transplantation. The patient was cured of his infection. A resistant virus was detected 20 months later that harboured the same TK gene mutation as the first resistant virus. This mutation is an insertion of one guanine in a homopolymer repeat of seven guanines located at codon 146 of TK. It has previously been reported and associated with the expression of a deficient TK activity and the ability to reactivate in mice. These results corroborate the clinical relevance of this mutation, which is associated with acyclovir-resistant recurrent infections in humans.
|
Authors | F Morfin, D Thouvenot, M Aymard, G Souillet |
Journal | Journal of medical virology
(J Med Virol)
Vol. 62
Issue 2
Pg. 247-50
(Oct 2000)
ISSN: 0146-6615 [Print] United States |
PMID | 11002255
(Publication Type: Case Reports, Journal Article)
|
Copyright | Copyright 2000 Wiley-Liss, Inc. |
Chemical References |
- Antiviral Agents
- Thymidine Kinase
- Acyclovir
|
Topics |
- Acyclovir
(pharmacology)
- Antiviral Agents
(pharmacology)
- Bone Marrow Transplantation
(adverse effects)
- Child
- Drug Resistance, Microbial
- Herpes Simplex
(diagnosis, virology)
- Herpesvirus 1, Human
(drug effects, enzymology, genetics, physiology)
- Humans
- Male
- Mutation
- Thymidine Kinase
(genetics, metabolism)
- Virus Activation
|